Contraceptive Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

Contraceptive method deals with the medical procedure or product that interferes with acts of sexual intercourse reproduction. Contraception methods are used to prevent pregnancy and it is a major factor affecting responsible for controlling worldwide pregnancy and birth rates. Contraception methods are widely used in developing countries to prevent teenage pregnancies. Widely increasing population is one of the key burdens on the world. There are more than 7 billion humans living on this earth. In last decade, world population has increased at a lucrative growth rate; thus contraception methods are playing the prime role in controlling world population and family planning. Close or poorly timed pregnancy may lead to high infant mortality rates thus contraception method help women to plan their pregnancy to give the best care after and before baby birth.

World female population is experiencing continuous growth and presently female population in the world is around 3.5 Billion. Maternal mortality is increasing day by day and approximately 800 women die every day as a result of poor, unplanned and unhealthy pregnancy and childbirth. As compared to older women, young pregnant women face a higher risk of complications and death as a result of pregnancy. As a result, contraception market is rapidly growing with the increasing awareness towards improving maternal health. Contraception market is driven by rising use of contraception drugs & devices and the introduction of new contraception products. In addition, contraception product has the strong hold on market due to increasing prevalence of sexually transmitted diseases. According to World Health Organization, more than 500 million people are suffering from genital infection with herpes simplex virus (HSV) while more than 290 million women have a human papilloma-virus (HPV) infection. However, increasing the prevalence of side effects due to improper use of contraception products and low use of contraception by poor women in developing countries may act as a roadblock to contraception market. Nonetheless, untapped market and newly launched contraception product are projected to generate new opportunities in next five years.

Based on the method type, the market of contraception has been classified into contraceptive pills, injectables, female sterilization, intrauterine devices & systems, male condom, emergency contraception and other. In developing countries, use of contraceptive pills is increasing in college students. Thus, contraceptive pills segment dominated the contraceptive market.  Female sterilization contraception is a permanent contraception procedure to prevent pregnancy. In 2015, female sterilization segment accounted for more than 25% market share. Thus, in the forecast period, these two segments are expected to exhibit noticeable growth due to rising awareness of personal care.

Based on the regional, the contraceptive market is classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominated the contraceptive market in 2015. North America contraceptive market was driven by increased awareness of women care and new emerging contraceptive products. Europe and Asia Pacific contraceptive market is projected to show healthy growth in coming years due to increasing investment in healthcare research and development.

Key operating players in contraceptive market are like The Female Health Company, Teva Pharmaceutical Industries, Bayer Healthcare Pharmaceuticals, Piramal Healthcare Limited, Reckitt Benckiser Plc., Cipla Limited, Novartis AG, Lupin Pharmaceuticals, Inc, Pfizer, Inc., Amgen Inc., Sun Pharmaceutical Industries Ltd., and Glenmark Pharmaceuticals.